KITLG and colorectal carcinoma: Recently, we have demonstrated that over-expression of miR-34c induced apoptosis and inhibited proliferation in CRC cells by silencing its target, stem cell factor (SCF, also known as KITLG) [12], suggesting miR-34c as a prominent target for the treatment of CRC patients.